Hillsdale Investment Management’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,300
Closed -$3.32M 757
2025
Q4
$3.32M Buy
66,300
+2,000
+3% +$96.1K 0.09% 282
2025
Q3
$3.16M Buy
+64,300
New +$3.29M 0.1% 269
2021
Q2
Sell
-500
Closed -$23K 644
2021
Q1
$23K Buy
+500
New +$20.9K ﹤0.01% 491
2018
Q3
Sell
-7,100
Closed -$375K 546
2018
Q2
$375K Hold
7,100
0.05% 256
2018
Q1
$355K Sell
7,100
-300
-4% -$15.1K 0.05% 254
2017
Q4
$355K Hold
7,400
0.06% 272
2017
Q3
$341K Buy
+7,400
New +$321K 0.06% 262

Other funds holding SNV

Hillsdale Investment Management's SNV Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Synovus (SNV) in Q1 2026, closing a stake of 66,300 shares — an estimated $3.32M sold.

Hillsdale Investment Management first reported a position in SNV in Q3 2017 and held it in 7 quarters. The position peaked at $3.32M in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Hillsdale Investment Management reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 66,300 Synovus shares in Q1 2026, an estimated $3.32M.
  • Hillsdale Investment Management first reported a position in Synovus in Q3 2017 and held it in 7 quarters.
  • Hillsdale Investment Management's Synovus position peaked at $3.32M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.